Assignee
EPIZYME INC
US·151 granted patents·169 pending applications·2,247 citations·filing 2012–2025
Top patents by PatentIndex Score
320 records- 0199US9475776B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Oct 25, 2016·32 cites·9 claims
- 0299US9365519B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Jun 14, 2016·34 cites·39 claims
- 0399US9206157B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2015·Granted Dec 8, 2015·28 cites·14 claims
- 0499US9120757B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 1, 2015·45 cites·36 claims
- 0599US9023883B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 5, 2015·46 cites·20 claims
- 0699US8993555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 31, 2015·50 cites·4 claims
- 0799US8962620B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Feb 24, 2015·31 cites·10 claims
- 0899US8598167B1Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2013·Granted Dec 3, 2013·34 cites·12 claims
- 0998US9943504B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Apr 17, 2018·14 cites·17 claims
- 1098US9675614B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jun 13, 2017·17 cites·23 claims
- 1198US9630961B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Apr 25, 2017·21 cites·24 claims
- 1298US9604930B2Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Mar 28, 2017·21 cites·35 claims
- 1398US9549931B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 24, 2017·39 cites·21 claims
- 1498US9532992B2Substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 3, 2017·32 cites·25 claims
- 1598US9522152B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Dec 20, 2016·32 cites·8 claims
- 1698US9394258B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jul 19, 2016·39 cites·13 claims
- 1798US9365527B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jun 14, 2016·35 cites·33 claims
- 1898US9346802B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted May 24, 2016·38 cites·32 claims
- 1998US9133189B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 15, 2015·45 cites·20 claims
- 2098US9090562B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jul 28, 2015·51 cites·20 claims
- 2198US8940726B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jan 27, 2015·47 cites·22 claims
- 2298US8906900B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Dec 9, 2014·44 cites·18 claims
- 2398US8765732B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2012·Granted Jul 1, 2014·66 cites·19 claims
- 2497US11642349B2Method for treating cancerEPIZYME INC·Filed 2020·Granted May 9, 2023·4 cites·11 claims
- 2597US11491163B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2020·Granted Nov 8, 2022·6 cites·10 claims
- 2697US11370781B2Combination therapy for treating cancerEPIZYME INC·Filed 2020·Granted Jun 28, 2022·4 cites·20 claims
- 2797US10118931B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Nov 6, 2018·19 cites·4 claims
- 2897US9765035B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Sep 19, 2017·15 cites·14 claims
- 2997US9718816B21-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Aug 1, 2017·25 cites·28 claims
- 3097US9440950B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2015·Granted Sep 13, 2016·34 cites·16 claims
- 3197US9394283B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2013·Granted Jul 19, 2016·27 cites·25 claims
- 3297US9365555B2PRMT5 inhibitors and uses thereofEPIZYME INC·Filed 2013·Granted Jun 14, 2016·37 cites·18 claims
- 3397US9334527B2Inhibitors of human EZH2, and methods of use thereofEPIZYME INC·Filed 2014·Granted May 10, 2016·39 cites·13 claims
- 3497US9089575B2Substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jul 28, 2015·19 cites·16 claims
- 3597US9045477B2Substituted 6,5-fused bicyclic heteroaryl compoundsEPIZYME INC·Filed 2014·Granted Jun 2, 2015·19 cites·17 claims
- 3697US9045455B2Arginine methyltransferase inhibitors and uses thereofEPIZYME INC·Filed 2014·Granted Jun 2, 2015·46 cites·20 claims
- 3797US9006242B2Substituted benzene compoundsEPIZYME INC·Filed 2013·Granted Apr 14, 2015·38 cites·18 claims
- 3896US11951109B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2021·Granted Apr 9, 2024·4 cites·14 claims
- 3996US11642348B2Substituted benzene compoundsEPIZYME INC·Filed 2020·Granted May 9, 2023·4 cites·12 claims
- 4096US11052093B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2019·Granted Jul 6, 2021·7 cites·20 claims
- 4196US10946024B2Method for treating cancerEPIZYME INC·Filed 2019·Granted Mar 16, 2021·7 cites·11 claims
- 4296US10787440B2Combination therapy for treating cancerEPIZYME INC·Filed 2019·Granted Sep 29, 2020·8 cites·20 claims
- 4396US10493076B2Method for treating cancerEPIZYME INC·Filed 2016·Granted Dec 3, 2019·7 cites·22 claims
- 4496US10369155B2Method for treating cancerEPIZYME INC·Filed 2017·Granted Aug 6, 2019·8 cites·20 claims
- 4596US10301290B2Combination therapy for treating cancerEPIZYME INC·Filed 2013·Granted May 28, 2019·13 cites·9 claims
- 4696US10155002B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Dec 18, 2018·16 cites·29 claims
- 4796US9889138B2Method for treating cancerEPIZYME INC·Filed 2016·Granted Feb 13, 2018·10 cites·35 claims
- 4896US9872862B2Salt form of a human histone methyltransferase EZH2 inhibitorEPIZYME INC·Filed 2016·Granted Jan 23, 2018·14 cites·17 claims
- 4996US9868703B2PRMT1 inhibitors and uses thereofEPIZYME INC·Filed 2016·Granted Jan 16, 2018·15 cites·2 claims
- 5096US9856267B2CARM1 inhibitors and uses thereofEPIZYME INC·Filed 2017·Granted Jan 2, 2018·14 cites·4 claims
Showing the top 50 of 320 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →